TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Obesity Treatment Market, by Type
6.1 Introduction
6.2 Inactivity Obesity
Market Estimates & Forecast, 2023-2030
6.3 Food Obesity
Market Estimates & Forecast, 2023-2030
6.4 Anxiety Obesity
Market Estimates & Forecast, 2023-2030
6.5 Venous Obesity
Market Estimates & Forecast, 2023-2030
6.6 Atherogenic Obesity
Market Estimates & Forecast, 2023-2030
6.7 Gluten Obesity
Market Estimates & Forecast, 2023-2030
Chapter 7. Global Obesity Treatment Market, by Diagnosis
7.1 Introduction
7.2 Blood Tests
Market Estimates & Forecast, 2023-2030
7.2.1 Cholesterol Tests
7.2.2 Liver Function Tests
7.2.3 Thyroid Tests
7.3 Physical Examination
Market Estimates & Forecast, 2023-2030
7.3.1 Heart Rate Measurement
7.3.2 Blood Pressure Measurement
7.3.3 Others
7.4 Others
Chapter 8. Global Obesity Treatment Market, by Treatment
8.1 Introduction
8.2 Medication
Market Estimates & Forecast, 2023-2030
8.2.1 Orlistat
8.2.2 Lorcaserin
8.2.3 Phentermine and Topiramate
8.2.4 Liraglutide
8.2.5 Others
8.3 Surgery
Market Estimates & Forecast, 2023-2030
8.3.1 Gastric Bypass Surgery
8.3.2 Laparoscopic Adjustable Gastric Banding (LAGB)
8.3.3 Gastric Sleeve
8.3.4 Biliopancreatic Diversion
8.3.5 Gastric Sleeve
8.3.6 Others
8.4 Lifestyle Changes
8.5 Others
Chapter 9. Global Obesity Treatment Market, by End-User
9.1 Introduction
9.2 Hospitals
Market Estimates & Forecast, 2023-2030
9.3 Clinics
Market Estimates & Forecast, 2023-2030
9.4 Pharmacies
Market Estimates & Forecast, 2023-2030
9.5 Others
Chapter 10. Global Obesity Treatment Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K.
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 VIVUS, Inc.
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 Arena Pharmaceuticals, Inc.
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 F. Hoffmann-La Roche, Ltd.
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Novo Nordisk A/S
12.4.1 Company Overview
12.4.2 Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Orexigen Therapeutics, Inc.
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Allergan
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Cousin Biotech
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 EnteroMedics, Inc.
12.8.1 Overview
12.8.2 Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Johnson & Johnson Services, Inc.
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Medtronic
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 USGI Medical, Inc.
12.11.1 Overview
12.11.2 Type Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Mediflex Surgical Products
12.12.1 Overview
12.12.2 Type Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 Covidien plc
12.13.1 Overview
12.13.2 Type Overview
12.13.3 Financials
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.14 Olympus Corporation
12.14.1 Overview
12.14.2 Type Overview
12.14.3 Financials
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.15 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Global Obesity Treatment Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Obesity Treatment Industry Synopsis, 2023-2030
Table 2 Global Obesity Treatment Market Estimates & Forecast, 2023-2030, (USD Million)
Table 3 Global Obesity Treatment Market, by Region, 2023-2030, (USD Million)
Table 4 Global Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 5 Global Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 6 Global Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 7 Global Obesity Treatment Market, by End-User, 2023-2030, (USD Million
Table 8 North America Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 9 North America Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 10 North America Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 11 North America Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 12 U.S. Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 13 U.S. Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 14 U.S. Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 15 U.S. Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 16 Canada Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 17 Canada Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 18 Canada Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 19 Canada Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 20 South America Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 21 South America Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 22 South America Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 23 South America Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 24 Europe Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 25 Europe Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 26 Europe Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 27 Europe Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 28 Western Europe Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 29 Western Europe Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 30 Western Europe Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 31 Western Europe Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 32 Eastern Europe Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 33 Eastern Europe Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 34 Eastern Europe Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 35 Eastern Europe Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 36 Asia Pacific Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 37 Asia Pacific Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 38 Asia Pacific Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 39 Asia Pacific Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
Table 40 The Middle East & Africa Obesity Treatment Market, by Type, 2023-2030, (USD Million)
Table 41 The Middle East & Africa Obesity Treatment Market, by Diagnosis, 2023-2030, (USD Million)
Table 42 The Middle East & Africa Obesity Treatment Market, by Treatment, 2023-2030, (USD Million)
Table 43 The Middle East & Africa Obesity Treatment Market, by End-User, 2023-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Obesity Treatment Market
Figure 3 Market Dynamics for Global Obesity Treatment Market
Figure 4 Global Obesity Treatment Market Share, by Type 2020
Figure 5 Global Obesity Treatment Market Share, by Diagnosis 2020
Figure 6 Global Obesity Treatment Market Share, by Treatment, 2020
Figure 7 Global Obesity Treatment Market Share, by End-User, 2020
Figure 8 Global Obesity Treatment Market Share, by Region, 2020
Figure 9 North America Obesity Treatment Market Share, by Country, 2020
Figure 10 Europe Obesity Treatment Market Share, by Country, 2020
Figure 11 Asia Pacific Obesity Treatment Market Share, by Country, 2020
Figure 12 The Middle East & Africa Obesity Treatment Market Share, by Country, 2020
Figure 13 Global Obesity Treatment Market: Company Share Analysis, 2020 (%)
Figure 14 VIVUS, Inc.: Key Financials
Figure 15 VIVUS, Inc.: Segmental Revenue
Figure 16 VIVUS, Inc.: Geographical Revenue
Figure 17 Arena Pharmaceuticals, Inc.: Key Financials
Figure 18 Arena Pharmaceuticals, Inc.: Segmental Revenue
Figure 19 Arena Pharmaceuticals, Inc.: Geographical Revenue
Figure 20 F. Hoffmann-La Roche, Ltd.: Key Financials
Figure 21 F. Hoffmann-La Roche, Ltd.: Segmental Revenue
Figure 22 F. Hoffmann-La Roche, Ltd.: Geographical Revenue
Figure 23 Novo Nordisk A/S: Key Financials
Figure 24 Novo Nordisk A/S: Segmental Revenue
Figure 25 Novo Nordisk A/S: Geographical Revenue
Figure 26 Orexigen Therapeutics, Inc.: Key Financials
Figure 27 Orexigen Therapeutics, Inc.: Segmental Revenue
Figure 28 Orexigen Therapeutics, Inc.: Geographical Revenue
Figure 29 Allergan: Key Financials
Figure 30 Allergan: Segmental Revenue
Figure 31 Allergan: Geographical Revenue
Figure 32 Cousin Biotech: Key Financials
Figure 33 Cousin Biotech: Segmental Revenue
Figure 34 Cousin Biotech: Geographical Revenue
Figure 35 EnteroMedics, Inc.: Key Financials
Figure 36 EnteroMedics, Inc.: Segmental Revenue
Figure 37 EnteroMedics, Inc.: Geographical Revenue
Figure 38 Johnson & Johnson Services, Inc.: Key Financials
Figure 39 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 40 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 41 Medtronic: Key Financials
Figure 42 Medtronic: Segmental Revenue
Figure 43 Medtronic: Geographical Revenue
Figure 44 USGI Medical, Inc.: Key Financials
Figure 45 USGI Medical, Inc.: Segmental Revenue
Figure 46 USGI Medical, Inc.: Geographical Revenue
Figure 47 Mediflex Surgical Products: Key Financials
Figure 48 Mediflex Surgical Products: Segmental Revenue
Figure 49 Mediflex Surgical Products: Geographical Revenue
Figure 50 Covidien plc: Key Financials
Figure 51 Covidien plc: Segmental Revenue
Figure 52 Covidien plc: Geographical Revenue
Figure 53 Olympus Corporation: Key Financials
Figure 54 Olympus Corporation: Segmental Revenue
Figure 55 Olympus Corporation: Geographical Revenue
